✨ Your Portfolio is fetched and updated from zerodha.

Emcure Pharmaceuticals Ltd.

EMCURE

Market Cap
₹22,211 Cr.
P/E
44.58

Emcure Pharmaceuticals Ltd.

About
Emcure Pharmaceuticals is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and global marketing of a wide range of pharmaceutical products across various thera… Read more
Emcure Pharmaceuticals is a prominent Indian pharmaceutical company specializing in the develo… Read more
Low
1110
52W Range
High
1580
  • Emcure Pharma
  • Natco Pharma
  • Concord Biotech

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Formulation

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Acute vs Chronic

Asset Break-Up - Geography Wise

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    FAQs on Emcure Pharmaceuticals Ltd. Business

    Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.

    Emcure Pharma major competitors are Natco Pharma, Concord Biotech, Gland Pharma, Eris Lifesciences, Pfizer, Wockhardt, JB Chem & Pharma.
    Market Cap of Emcure Pharma is ₹22,211 Crs.
    While the median market cap of its peers are ₹23,384 Crs.

    Emcure Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Emcure Pharma is 4.7 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Mar Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material